London [UK], September 18 (ANI): An immunotherapy drug called 'avelumab' has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial.
Washington D.C. [USA], April 12 (ANI): Treating metastatic bladder cancer patients with immunotherapy immediately after their chemotherapy significantly slows down the progression of cancer, suggests a study based on a clinical trial.
Washington D.C.[USA], April 10 (ANI): The results of a clinical trial show using immunotherapy immediately after chemotherapy treatment in patients with metastatic bladder cancer significantly slowed the progression of cancer.